Publications

The SENTRY Asia-Pacific participants: Regional variation in the prevalence of extended-spectrum ß-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). by Hirakata Y, Matsuda J, Miyazaki Y, Kamihira S, Kawakami S, Miyazawa Y, Ono Y, Nakazaki N, Hirata Y, Inoue M, Turnidge JD, Bell JM, Jones RN and Kohno S published in Diagn. Microbiol. Infect. Dis. 2005; 52 (4): 323-329

Potency and spectrum trends for cefepime tested against 65,746 clinical bacterial isolates collected in North American medical centers: Results from the SENTRY Antimicrobial Surveillance Program (1998 – 2003). by Sader HS, Fritsche TR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2005; 52 (3): 265-273

Emerging metallo-b-lactamase-mediated resistances: A summary report from the worldwide SENTRY Antimicrobial Surveillance Program. by Fritsche TR, Sader HS, Toleman MA, Walsh TR and Jones RN published in Clin. Infect. Dis. 2005; 41 (Suppl 4): S276-S278

Italian metallo-β-lactamases: A national problem? Report from the SENTRY Antimicrobial Surveillance Programme. by Toleman, M.A., Biedenbach, D., Bennett, D.M.C., Jones, R.N., Walsh, T.R published in J. Antimicrob. Chemother. 2005; 55 (1): 61-70

Comparative activity of oral and parenteral cephalosporins tested against multidrug-resistant Streptococcus pneumoniae: Report from the SENTRY Antimicrobial Surveillance Program (1997 – 2003). by Pottumarthy, S., Fritsche, T.R., Jones, R.N. published in Diagn. Microbiol. Infect. Dis. 2005; 51 (2): 147-150

Evolution and dissemination of extended-spectrum β-lactamase-producing Klebsiella pneumoniae: Epidemiology and molecular report from the SENTRY Antimicrobial Surveillance Program (1997 – 2003). by DiPersio JR, Deshpande LM, Biedenbach DJ, Toleman MA, Walsh TR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2005; 51 (1): 1-7

Evaluation of alternative disk diffusion methods for detecting mecA-mediated oxacillin resistance in an international collection of staphylococci: Validation report from the SENTRY Antimicrobial Surveillance Program. by Pottumarthy S, Fritsche TR, Jones RN published in Diagn. Microbiol. Infect. Dis. 2005; 51 (1):57-62

Integron carrying a novel metallo-beta-lactamase gene, bla_IMP-16, and a fused form of aminoglycoside-resistant gene aac(6’)-30/aac(6’)-Ib’: Report from the SENTRY Antimicrobial Surveillance Program. by Mendes RE, Toleman MA, Ribeiro J, Sader HS, Jones RN and Walsh TR published in Antimicrob. Agents Chemother. 2004; 48 (12): 4693-4702

Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). by Bidenbach DJ, Moet GJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 2004; 50 (1): 59-69

Activity of mupirocin and 14 additional antibiotics against staphylococci isolated from Latin American Hospitals: Report from the SENTRY Antimicrobial Surveillance Program. by Gales AC, Andrade SS, Sader HS and Jones RN published in J. Chemother. 2004; 16 (4):323-328

Resistance Trends of Acinetobacter spp. in Latin America and Characterization of International Dissemination of Multi-Drug Resistant Strains: Five-Year Report of the SENTRY Antimicrobial Surveillance Program. by Tognim MCB, Andrade SS, Silbert S, Gales AC, Jones RN and Sader HS published in Int. J. Infect. Dis. 2004; 8 (5): 284-291

Evaluation of the contemporary occurrence rates of metallo-beta-lactamases in multidrug-resistant Gram-negative bacilli in Japan: Report from the SENTRY Antimicrobial Surveillance Program (1998-2002). by Jones RN, Deshpande LM, Bell JM, Turnidge JD, Kohno S, Hirakata Y, Ono Y, Miyazawa Y, Kawakama S, Inoue M, Hirato Y and Toleman MA published in Diagn. Microbiol. Infect. Dis. 2004; 49 (4): 289-294

Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: Report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). by Streit JM, Jones RN, Sader HS and Fritsche TR published in Int. J. Antimicrob. Agents 2004; 24 (2): 111-118

Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: Results from five years of the SENTRY Antimicrobial Surveillance Program. by Castanheira M, Gales AC, Mendes RE, Jones RN and Sader HS published in Clin. Microbiol. Infect. 2004; 10 (7): 645-651

Antimicrobial activities of garenoxacin (BMS 284756) against Asia-Pacific region clinical isolates from the SENTRY Program, 1999 to 2001. by Christiansen KJ, Bell JM, Turnidge JD, Jones RN published in Antimicrob. Agents Chemother. 2004; 48 (6): 2049-2055

Emergence of the extended-spectrum beta-lactamase GES-1 in a Pseudomonas aeruginosa strain from Brazil: Report from the SENTRY Antimicrobial Surveillance Program. by Castanheira M, Mendes RE, Walsh TR, Gales AC and Jones RN published in Antimicrob. Agents Chemother. 2004; 48 (6): 2344-2345

Letters to the editor: First isolation of bla_VIM-2 in Latin America: Report from the SENTRY Antimicrobial Surveillance Program. by Mendes RE, Castanheira M, Garcia P, Guzman M, Toleman MA, Walsh TR and Jones RN published in Antimicrob. Agents Chemother. 2004; 48 (4): 1433-1434

Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp.: Report from the SENTRY Antimicrobial Surveillance Program (1997-2001). by Kirby JT, Sader HS, Walsh TR and Jones RN published in J. Clin. Microbiol. 2004; 42 (1): 445-448

Are Enterococcus faecalis strains with vat(E) in poultry a reservoir for human streptogramin resistance? vat(E) occurrence in human enterococcal bloodstream infections in North America (SENTRY Antimicrobial Surveillance Program, 2002). by Jones RN, Deshpande LM published in Antimicrob. Agents Chemother. 2004; 48 (1): 360-361

Ability of Latin America laboratories to detect antimicrobial resistance patterns: experience of the SENTRY Antimicrobial Surveillance Program (1997-2000). by Mendes RE, Reis AO, Gales AC, Jones RN and Sader HS published in Braz. J. Infect. Dis. 2003; 7 (5): 282-289

Epidemiology and frequency of antimicrobial resistances among pathogens causing surgical site infections: Report from the SENTRY Antimicrobial Surveillance Program in the United States, Canada, and Europe. by Mathai D, Biedenbach DJ, Jones RN published in Clin. Microbiol. Infect. 2003; 9 (Suppl 1):287-288

Sustained activity and spectrum of selected extended-spectrum beta-lactams (carbapenems and cefepime) against Enterobacter spp. and ESBL-producing Klebsiella spp.: Report from the SENTRY Antimicrobial Surveillance Program (USA, 1997-2000). by Jones RN, Biedenbach DJ and Gales AC published in Int. J. Antimicrob. Agents 2003; 21 (1): 1-7

Genetic characterization of a novel metallo-ß-lactamase gene, bla_IMP-13, harboured by a novel Tn5051-type transposon disseminating carbapenemase genes in Europe: Report from the SENTRY Worldwide Antimicrobial Surveillance Programme. by Toleman MA, Biedenbach D, Bennett D, Jones RN and Walsh TR published in J. Antimicrob. Chemother. 2003; 52 (4): 583-590

Frequency of occurrence and antimicrobial susceptibility of bacterial pathogens from intensive care units in Latin American medical centers: Report from the SENTRY Antimicrobial Surveillance Program by Sader HS, Gales AC, Mendes RE and Jones RN on Behalf of the SENTRY Group – Latin America published in Clin. Microbiol. Infect. 2003; 9 (Suppl 1): 226

Salmonella bloodstream infections: Report from the SENTRY Antimicrobial Surveillance Program (1997-2001). by Stephen JM, Toleman MA, Walsh TR, Jones RN, SENTRY Program Participants Group published in Int. J. Antimicrob. Agents 2003; 22 (4): 395-405

Epidemiology of the new metallo-beta-lactamase gene blaSPM, in South America: Report from the SENTRY Antimicrobial Surveillance Program. Abstr. P718. by Toleman M, Bennett D, Walsh T, Jones RN published in Clin. Microbiol. Infect. 2003; 9 (Suppl 1):156-157

Comparative activity and spectrum of broad-spectrum ß-Lactams (cefepime, ceftazidime, ceftriaxone, piperacillin/tazobactam) tested against 12,295 staphylococci and streptococci: Report from the SENTRY Antimicrobial Surveillance Program (North America: 2001-2002). by Fritsche TR, Sader HS, Jones RN published in Diagn. Microbiol. Infect. Dis. 2003; 47 (2): 435-440

Evolution of an integron carrying blaVIM-2 in Central Europe: Report from the SENTRY Antimicrobial Surveillance Program. Abstr. P717. by Toleman MA, Hryniewicz W, Bennett P, Jones RN and Walsh TR published in Clin Microbiol Infect 2003; 9 (Suppl 1): 156

Actividad in vitro comparativa de garenoxacino (BMS-284756). Programa SENTRY Espana (1999-2000). by Loza E, Canton R, Pascual A, Tubau F, Morosini MI, Almaraz F, Perea E, Martin R and Jones RN published in Enferm. Infecc. Microbiol. Clin. 2003; 21 (8):404-409

Prevalence and resistance rates of Enterobacter spp. in nosocomial infections, Euro-SENTRY Antimicrobial Surveillance Program, 1997 – 2001. Abstr. P714. by Rodriguez-Villalobos H, Struelens MJ and Jones RN on Behalf of the Euro-SENTRY Participants published in Clin. Microbiol. Infect. 2003; 9 (Suppl 1): 155

Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48,440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2001). by Sader HS, Biedenbach DJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 2003; 47 (1): 361-364

Cloning of a hybrid metallo-beta-lactamase gene conferring a novel IMP variant blaIMP-13 in Pseudomonas aeruginosa in Italy: Report from the SENTRY Antimicrobial Surveillance Program by Toleman MA, Jones RN, Walsh TR published in Clin. Microbiol. Infect. 2003; 9 (Suppl 1): 119

Susceptibility trends of Haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: Five-year report from the SENTRY Antimicrobial Surveillance Program. by Johnson DM, Sader HS, Fritsche TR, Biedenbach DJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 2003; 47 (1): 373-376

Analysis of the blaVIM gene context from Italy reveals novel resistant cassettes: Report from the SENTRY Antimicrobial Surveillance Program. by Toleman MA, Bennett D, Jones RN, Walsh TR published in Clin. Microbiol. Infect. 2003; 9 (Suppl 1): 119

Comparison of Streptococcus pneumoniae and Haemophilus infuenzae,/i> susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: Five-year results for the SENTRY Antimicrobial Surveillance Program. by Gordon KA, Biedenbach DJ, Jones RN published in Diagn. Microbiol. Infect. Dis. 2003; 46 (4): 285-289

Over-expression of a novel RamA from Enterobacter cloacae confers carbapenem resistance in E. coli: Report from the SENTRY Antimicrobial Surveillance Program by Toleman MA, Jones RN and Walsh TR published in Clin. Microbiol. Infect. 2003; 9 (Suppl 1): 53-54

Antimicrobial susceptibility profile among ß-haemolytic Streptococcus spp. collected in the SENTRY Antimicrobial Surveillance Program – North America, 2001. by Biedenbach DJ, Stephen JM and Jones RN published in Diagn. Microbiol. Infect. Dis. 2003; 46 (4): 291-294

Influence of patient age on the susceptibility patterns of Streptococcus pneumoniae isolates in North America (2000 – 2001): Report from the SENTRY Antimicrobial Surveillance Program. by Jones RN, Biedenbach DJ and Beach ML published in Diagn. Microbiol. Infect. Dis. 2003; 46 (1): 77-80

Quinupristin/dalfopristin resistance in Streptococcus pneumoniae: Novel L22 ribosomal protein mutation in two clinical isolates from the SENTRY Antimicrobial Surveillance Program. by Jones RN, Farrell DJ and Morrisey I published in Antimicrob. Agents Chemother. 2003; 47 (8): 2696-2698

Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones: Prevalence results from the SENTRY Antimicrobial Surveillance Program. by Biedenbach DJ, Jones RN published in Diagn. Microbiol. Infect. Dis. 2003; 46 (1): 55-61

Distribution of fsr among Enterococcus faecalis isolates from the SENTRY Antimicrobial Surveillance Program. by Jones RN, Deshpande LM published in J. Clin. Microbiol. 2003; 41 (8): 4004-4005

Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY Antimicrobial Surveillance Program (1997 – 2000). by Mutnick AH, Biedenbach DJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 2003; 46 (1): 63-68

Evolution of an integron carrying blaVIM-2 in Eastern Europe: Report from the SENTRY Antimicrobial Surveillance Program. by Walsh TR, Toleman MA, Hryniewicz W, Bennett PM and Jones RN published in J. Antimicrob. Chemother. 2003; 52 (1): 116-119

Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: Comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000). by Gordon KA, Jones RN and The SENTRY Participant Groups (Europe, Latin America, North America) published in Diagn. Microbiol. Infect. Dis. 2003; 45 (4): 295-301

Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centers: Five year report of the SENTRY Antimicrobial Surveillance Program (1997-2001). by Andrade SS, Jones RN, Gales AC and Sader HS published in J. Antimicrob. Chemother. 2003; 52 (1): 140-141

Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: Report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000). by Rennie RP, Jones RN, Mutnick AH and The SENTRY Program Study Group (North America) published in Diagn. Microbiol. Infect. Dis. 2003; 45 (4): 287-293

Resistance to ß-lactams among blood isolates of Salmonella spp. in European hospitals: Results from the SENTRY Antimicrobial Surveillance Program 1997-98. by Tzouvelekis LS, Lukova V, Tassios PT, Fluit AC, Jones RN and Legakis NJ published in Clin. Microbiol. Infect. 2003; 9 (2): 149-152

Linezolid resistance since 2001: SENTRY Antimicrobial Surveillance Program. by Mutnick AH, Enne V and Jones RN published in Ann. Pharmacol. 2003; 37 (6): 769-774

Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: Results of the SENTRY Antimicrobial Surveillance Study (2000). by Hoban DJ, Biedenbach DJ, Mutnick AH and Jones RN published in Diagn. Microbiol. Infect. Dis. 2003; 45 (4): 279-285

Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18,569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001). by Jones RN, Sader HS, Beach ML published in Int. J. Antimicrob. Agents 2003; 22 (6): 551-556